| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Low Back Pain | 15 | 2020 | 987 | 2.220 |
Why?
|
| Pain Perception | 11 | 2018 | 198 | 1.820 |
Why?
|
| Placebo Effect | 16 | 2021 | 514 | 1.730 |
Why?
|
| Brain | 61 | 2025 | 27171 | 1.630 |
Why?
|
| Schizophrenia | 35 | 2017 | 6972 | 1.600 |
Why?
|
| Prefrontal Cortex | 19 | 2021 | 2224 | 1.530 |
Why?
|
| Acupuncture Analgesia | 7 | 2021 | 62 | 1.520 |
Why?
|
| Brain Mapping | 38 | 2021 | 6601 | 1.490 |
Why?
|
| Pain Threshold | 12 | 2021 | 604 | 1.410 |
Why?
|
| Acupuncture Therapy | 8 | 2020 | 466 | 1.360 |
Why?
|
| Memory, Short-Term | 12 | 2015 | 1003 | 1.190 |
Why?
|
| Magnetic Resonance Imaging | 87 | 2025 | 36532 | 1.160 |
Why?
|
| Pain | 23 | 2021 | 5077 | 1.160 |
Why?
|
| Neural Pathways | 20 | 2020 | 3085 | 1.130 |
Why?
|
| Cerebral Cortex | 21 | 2020 | 5767 | 0.980 |
Why?
|
| Pain Measurement | 24 | 2020 | 3561 | 0.920 |
Why?
|
| Periaqueductal Gray | 5 | 2015 | 111 | 0.870 |
Why?
|
| Image Processing, Computer-Assisted | 27 | 2021 | 8923 | 0.840 |
Why?
|
| Catechol O-Methyltransferase | 6 | 2014 | 251 | 0.830 |
Why?
|
| Hyperalgesia | 6 | 2021 | 514 | 0.760 |
Why?
|
| Osteoarthritis, Knee | 6 | 2018 | 1248 | 0.740 |
Why?
|
| Nerve Net | 10 | 2020 | 2309 | 0.710 |
Why?
|
| Hippocampus | 10 | 2017 | 3775 | 0.660 |
Why?
|
| Arthralgia | 2 | 2018 | 459 | 0.550 |
Why?
|
| Somatosensory Cortex | 3 | 2020 | 510 | 0.530 |
Why?
|
| Young Adult | 54 | 2021 | 59889 | 0.500 |
Why?
|
| Memory Disorders | 4 | 2014 | 1194 | 0.500 |
Why?
|
| Frontal Lobe | 8 | 2015 | 1410 | 0.470 |
Why?
|
| Adult | 94 | 2021 | 223044 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 12 | 2017 | 16047 | 0.450 |
Why?
|
| Basal Ganglia | 4 | 2019 | 549 | 0.430 |
Why?
|
| Longevity | 1 | 2021 | 1087 | 0.420 |
Why?
|
| Music Therapy | 1 | 2014 | 111 | 0.410 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 298 | 0.410 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 9 | 2017 | 2798 | 0.400 |
Why?
|
| Empathy | 2 | 2020 | 474 | 0.390 |
Why?
|
| Genetic Loci | 5 | 2020 | 2631 | 0.390 |
Why?
|
| Analgesia | 3 | 2021 | 461 | 0.390 |
Why?
|
| Genome-Wide Association Study | 8 | 2020 | 12807 | 0.390 |
Why?
|
| Cognition Disorders | 8 | 2017 | 3967 | 0.370 |
Why?
|
| Rest | 6 | 2019 | 942 | 0.360 |
Why?
|
| Male | 98 | 2024 | 363698 | 0.360 |
Why?
|
| Lateral Thalamic Nuclei | 1 | 2020 | 9 | 0.360 |
Why?
|
| Catastrophization | 3 | 2019 | 352 | 0.350 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2020 | 43 | 0.350 |
Why?
|
| Female | 100 | 2024 | 396112 | 0.350 |
Why?
|
| Temporal Lobe | 6 | 2012 | 1714 | 0.340 |
Why?
|
| Neostriatum | 1 | 2011 | 231 | 0.340 |
Why?
|
| Agnosia | 1 | 2020 | 67 | 0.330 |
Why?
|
| Humans | 138 | 2025 | 765968 | 0.330 |
Why?
|
| Consciousness | 2 | 2015 | 601 | 0.330 |
Why?
|
| Electroacupuncture | 2 | 2010 | 59 | 0.330 |
Why?
|
| Middle Aged | 59 | 2024 | 223009 | 0.320 |
Why?
|
| Acupuncture Points | 4 | 2013 | 97 | 0.310 |
Why?
|
| Touch Perception | 1 | 2020 | 105 | 0.310 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2025 | 361 | 0.310 |
Why?
|
| Gyrus Cinguli | 7 | 2019 | 1117 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 9 | 2012 | 3356 | 0.290 |
Why?
|
| Organ Size | 7 | 2020 | 2260 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 4392 | 0.280 |
Why?
|
| Cognition | 8 | 2024 | 7049 | 0.280 |
Why?
|
| Thalamus | 7 | 2014 | 1048 | 0.280 |
Why?
|
| Reward | 4 | 2020 | 981 | 0.280 |
Why?
|
| Genetic Variation | 3 | 2020 | 6610 | 0.280 |
Why?
|
| Myelin Sheath | 2 | 2015 | 652 | 0.280 |
Why?
|
| Parietal Lobe | 3 | 2015 | 858 | 0.270 |
Why?
|
| Oxygen | 10 | 2018 | 4241 | 0.270 |
Why?
|
| Amygdala | 4 | 2019 | 1377 | 0.260 |
Why?
|
| Fibromyalgia | 3 | 2015 | 406 | 0.260 |
Why?
|
| Caffeine | 1 | 2021 | 702 | 0.260 |
Why?
|
| Hot Temperature | 4 | 2015 | 1433 | 0.260 |
Why?
|
| Neuropsychological Tests | 12 | 2017 | 7123 | 0.240 |
Why?
|
| Attention | 4 | 2021 | 2419 | 0.240 |
Why?
|
| Back Pain | 1 | 2019 | 544 | 0.240 |
Why?
|
| Video Recording | 1 | 2019 | 969 | 0.220 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 706 | 0.220 |
Why?
|
| DNA Methylation | 2 | 2015 | 4424 | 0.220 |
Why?
|
| Physical Stimulation | 4 | 2019 | 513 | 0.210 |
Why?
|
| Medical Informatics | 3 | 2010 | 745 | 0.210 |
Why?
|
| Placebos | 5 | 2019 | 1659 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2017 | 18071 | 0.210 |
Why?
|
| Models, Neurological | 3 | 2012 | 1747 | 0.200 |
Why?
|
| Schizophrenic Psychology | 4 | 2015 | 1648 | 0.200 |
Why?
|
| Functional Laterality | 6 | 2014 | 2243 | 0.200 |
Why?
|
| Maternal Behavior | 1 | 2014 | 306 | 0.200 |
Why?
|
| Adolescent | 22 | 2021 | 88835 | 0.200 |
Why?
|
| Conditioning, Classical | 1 | 2014 | 368 | 0.190 |
Why?
|
| Emotions | 3 | 2015 | 2763 | 0.190 |
Why?
|
| Corpus Callosum | 3 | 2017 | 751 | 0.190 |
Why?
|
| Biomedical Research | 4 | 2015 | 3458 | 0.190 |
Why?
|
| Cues | 4 | 2014 | 877 | 0.190 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 1881 | 0.190 |
Why?
|
| Diffusion Tensor Imaging | 6 | 2020 | 2410 | 0.190 |
Why?
|
| Nervous System | 1 | 2015 | 542 | 0.190 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 1445 | 0.190 |
Why?
|
| Diagnostic Imaging | 4 | 2022 | 3529 | 0.190 |
Why?
|
| Cerebral Infarction | 2 | 2014 | 970 | 0.180 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 3819 | 0.180 |
Why?
|
| Diprenorphine | 2 | 2014 | 13 | 0.180 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 499 | 0.180 |
Why?
|
| Analysis of Variance | 5 | 2021 | 6203 | 0.170 |
Why?
|
| Visual Perception | 1 | 2019 | 1394 | 0.170 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2011 | 162 | 0.170 |
Why?
|
| Personality | 1 | 2014 | 560 | 0.170 |
Why?
|
| Cross-Over Studies | 4 | 2021 | 2108 | 0.170 |
Why?
|
| Principal Component Analysis | 3 | 2014 | 951 | 0.170 |
Why?
|
| Single-Blind Method | 3 | 2020 | 1589 | 0.160 |
Why?
|
| Leukoencephalopathies | 2 | 2012 | 259 | 0.160 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2013 | 952 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2015 | 3785 | 0.160 |
Why?
|
| Psychophysics | 3 | 2015 | 294 | 0.150 |
Why?
|
| Anisotropy | 5 | 2020 | 1282 | 0.150 |
Why?
|
| Homeodomain Proteins | 3 | 2018 | 2428 | 0.150 |
Why?
|
| Genetic Association Studies | 4 | 2015 | 2741 | 0.150 |
Why?
|
| Sex Characteristics | 2 | 2015 | 2643 | 0.150 |
Why?
|
| Databases, Factual | 3 | 2018 | 8067 | 0.150 |
Why?
|
| Technology Transfer | 1 | 2008 | 41 | 0.150 |
Why?
|
| Brain Injuries | 2 | 2025 | 2060 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2021 | 3719 | 0.150 |
Why?
|
| Motivation | 1 | 2018 | 2018 | 0.150 |
Why?
|
| Child | 14 | 2021 | 80564 | 0.140 |
Why?
|
| Beta Rhythm | 1 | 2018 | 65 | 0.140 |
Why?
|
| Skull | 2 | 2018 | 811 | 0.140 |
Why?
|
| Infant, Newborn | 7 | 2025 | 26346 | 0.140 |
Why?
|
| Food, Fortified | 1 | 2018 | 189 | 0.140 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1740 | 0.140 |
Why?
|
| Genes, Homeobox | 1 | 2018 | 287 | 0.140 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 92 | 0.130 |
Why?
|
| Case-Control Studies | 12 | 2020 | 22223 | 0.130 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 77 | 0.130 |
Why?
|
| Aged | 20 | 2024 | 171117 | 0.130 |
Why?
|
| Algorithms | 7 | 2019 | 14071 | 0.130 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 59489 | 0.130 |
Why?
|
| Database Management Systems | 1 | 2007 | 263 | 0.130 |
Why?
|
| Neural Tube Defects | 1 | 2018 | 256 | 0.130 |
Why?
|
| Learning | 1 | 2015 | 1755 | 0.130 |
Why?
|
| Cohort Studies | 10 | 2021 | 41649 | 0.130 |
Why?
|
| Neurosciences | 1 | 2010 | 385 | 0.130 |
Why?
|
| Neuralgia | 1 | 2012 | 625 | 0.130 |
Why?
|
| Phenotype | 5 | 2016 | 16721 | 0.120 |
Why?
|
| Vision, Ocular | 1 | 2009 | 457 | 0.120 |
Why?
|
| Narcotics | 1 | 1997 | 332 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 11888 | 0.120 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1995 | 171 | 0.120 |
Why?
|
| Nucleus Accumbens | 1 | 1997 | 360 | 0.120 |
Why?
|
| Auditory Cortex | 1 | 2009 | 364 | 0.120 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 204 | 0.110 |
Why?
|
| Mental Status Schedule | 1 | 2015 | 315 | 0.110 |
Why?
|
| Evoked Potentials | 1 | 2010 | 1048 | 0.110 |
Why?
|
| Neurogranin | 1 | 2013 | 15 | 0.110 |
Why?
|
| Photic Stimulation | 3 | 2015 | 1993 | 0.110 |
Why?
|
| Pattern Recognition, Automated | 1 | 2010 | 978 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 4808 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2021 | 42500 | 0.110 |
Why?
|
| Smoking | 3 | 2013 | 9081 | 0.110 |
Why?
|
| Corpus Striatum | 2 | 2014 | 1218 | 0.110 |
Why?
|
| Cortical Synchronization | 1 | 2014 | 76 | 0.110 |
Why?
|
| Apraxias | 1 | 2014 | 58 | 0.110 |
Why?
|
| Putamen | 1 | 2015 | 289 | 0.110 |
Why?
|
| Infant | 6 | 2021 | 36386 | 0.110 |
Why?
|
| Caudate Nucleus | 1 | 2015 | 387 | 0.110 |
Why?
|
| Drug Discovery | 1 | 2011 | 1064 | 0.110 |
Why?
|
| Migraine Disorders | 1 | 2016 | 1732 | 0.110 |
Why?
|
| Cerebellum | 2 | 2012 | 1518 | 0.100 |
Why?
|
| Punishment | 1 | 2014 | 95 | 0.100 |
Why?
|
| Statistics, Nonparametric | 2 | 2017 | 2844 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2008 | 721 | 0.100 |
Why?
|
| Thinking | 1 | 2016 | 322 | 0.100 |
Why?
|
| Gene Duplication | 1 | 2014 | 317 | 0.100 |
Why?
|
| Parahippocampal Gyrus | 1 | 2013 | 117 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 2 | 2011 | 2674 | 0.100 |
Why?
|
| Cocaine | 1 | 1997 | 946 | 0.100 |
Why?
|
| Glutamate Decarboxylase | 1 | 2013 | 240 | 0.100 |
Why?
|
| Problem Solving | 1 | 2004 | 440 | 0.100 |
Why?
|
| Positron-Emission Tomography | 3 | 2014 | 6547 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1066 | 0.090 |
Why?
|
| Acoustic Stimulation | 2 | 2010 | 1255 | 0.090 |
Why?
|
| Folic Acid | 1 | 2018 | 1338 | 0.090 |
Why?
|
| Visual Cortex | 1 | 2009 | 1085 | 0.090 |
Why?
|
| Attitude to Health | 1 | 2010 | 2020 | 0.090 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2012 | 240 | 0.090 |
Why?
|
| Carotid Artery, Internal | 1 | 2013 | 437 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 945 | 0.090 |
Why?
|
| Mental Disorders | 3 | 2010 | 6853 | 0.090 |
Why?
|
| Radiology Information Systems | 1 | 2015 | 532 | 0.090 |
Why?
|
| Spin Labels | 2 | 2012 | 334 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1721 | 0.090 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 15880 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 1429 | 0.080 |
Why?
|
| Serotonin | 1 | 1994 | 1049 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 3278 | 0.080 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 834 | 0.080 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2012 | 541 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2017 | 2195 | 0.080 |
Why?
|
| Dementia | 1 | 2024 | 2744 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2015 | 1195 | 0.080 |
Why?
|
| Forearm | 2 | 2012 | 427 | 0.080 |
Why?
|
| Sensory Thresholds | 1 | 2020 | 377 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 3 | 2009 | 1731 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2008 | 1546 | 0.080 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2013 | 537 | 0.080 |
Why?
|
| Extremities | 1 | 2014 | 869 | 0.080 |
Why?
|
| Qi | 1 | 2007 | 15 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2018 | 12131 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9525 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2018 | 2590 | 0.070 |
Why?
|
| Sleep | 1 | 2024 | 4813 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2014 | 6014 | 0.070 |
Why?
|
| Executive Function | 1 | 2016 | 1391 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2015 | 7851 | 0.070 |
Why?
|
| Aging | 2 | 2018 | 8731 | 0.070 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2008 | 276 | 0.070 |
Why?
|
| Galvanic Skin Response | 2 | 2015 | 359 | 0.070 |
Why?
|
| Reaction Time | 3 | 2009 | 2086 | 0.070 |
Why?
|
| Genotype | 5 | 2017 | 13024 | 0.070 |
Why?
|
| Neurons, Afferent | 1 | 2019 | 497 | 0.070 |
Why?
|
| Meditation | 1 | 2000 | 256 | 0.070 |
Why?
|
| Random Allocation | 1 | 2021 | 2395 | 0.070 |
Why?
|
| Chronic Disease | 4 | 2014 | 9347 | 0.060 |
Why?
|
| Carotid Stenosis | 1 | 2013 | 861 | 0.060 |
Why?
|
| Tobacco Use Disorder | 1 | 2012 | 708 | 0.060 |
Why?
|
| Polymorphism, Genetic | 2 | 2014 | 4247 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 2531 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2014 | 5189 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2013 | 1425 | 0.060 |
Why?
|
| Subliminal Stimulation | 1 | 2014 | 8 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2013 | 1142 | 0.060 |
Why?
|
| Physicians | 1 | 2013 | 4588 | 0.060 |
Why?
|
| Perceptual Masking | 1 | 2014 | 90 | 0.060 |
Why?
|
| Needles | 1 | 2007 | 460 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2021 | 12437 | 0.060 |
Why?
|
| Personality Tests | 1 | 2014 | 80 | 0.060 |
Why?
|
| Capsaicin | 1 | 2015 | 226 | 0.060 |
Why?
|
| Mental Processes | 1 | 2015 | 243 | 0.060 |
Why?
|
| Atlases as Topic | 1 | 2015 | 246 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2014 | 6322 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 491 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2015 | 20124 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3607 | 0.050 |
Why?
|
| Internet | 1 | 2006 | 3106 | 0.050 |
Why?
|
| Systems Integration | 2 | 2015 | 427 | 0.050 |
Why?
|
| Motor Cortex | 1 | 2010 | 1003 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2660 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 1996 | 1006 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5786 | 0.050 |
Why?
|
| Brain Stem | 2 | 2012 | 853 | 0.050 |
Why?
|
| Uncertainty | 1 | 2017 | 761 | 0.050 |
Why?
|
| Anticipation, Psychological | 1 | 2012 | 90 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2020 | 65188 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 14751 | 0.050 |
Why?
|
| Lidocaine | 1 | 2015 | 550 | 0.050 |
Why?
|
| Software | 1 | 2006 | 4462 | 0.050 |
Why?
|
| Hypnosis | 1 | 2012 | 83 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2021 | 1461 | 0.050 |
Why?
|
| Neurofeedback | 1 | 2012 | 50 | 0.050 |
Why?
|
| Antipsychotic Agents | 2 | 2013 | 3076 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 1997 | 4416 | 0.040 |
Why?
|
| Autopsy | 1 | 2014 | 1011 | 0.040 |
Why?
|
| Sleep, REM | 1 | 2024 | 588 | 0.040 |
Why?
|
| Awareness | 1 | 2014 | 653 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2013 | 366 | 0.040 |
Why?
|
| Pressure | 1 | 2013 | 1168 | 0.040 |
Why?
|
| Dogs | 1 | 2014 | 3822 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2352 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2009 | 222 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2013 | 547 | 0.040 |
Why?
|
| Research Design | 2 | 2011 | 6209 | 0.040 |
Why?
|
| Apoptosis | 1 | 2015 | 9514 | 0.040 |
Why?
|
| Reference Values | 3 | 2012 | 4908 | 0.040 |
Why?
|
| Apraxia, Ideomotor | 1 | 2018 | 4 | 0.040 |
Why?
|
| Illusions | 1 | 2008 | 62 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2012 | 533 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 1456 | 0.040 |
Why?
|
| Mutation | 3 | 2018 | 30198 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 1015 | 0.040 |
Why?
|
| Philadelphia | 1 | 2018 | 267 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2014 | 1128 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 1509 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4034 | 0.040 |
Why?
|
| Psychomotor Disorders | 1 | 2008 | 149 | 0.040 |
Why?
|
| Models, Biological | 1 | 2014 | 9443 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2009 | 303 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15398 | 0.040 |
Why?
|
| Self Report | 1 | 2019 | 3770 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2014 | 1820 | 0.030 |
Why?
|
| Pons | 1 | 2008 | 238 | 0.030 |
Why?
|
| Nonlinear Dynamics | 2 | 2012 | 490 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 2008 | 543 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 130 | 0.030 |
Why?
|
| Down Syndrome | 2 | 2016 | 915 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2011 | 3270 | 0.030 |
Why?
|
| Vitamin B Complex | 1 | 2018 | 299 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 10383 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2017 | 258 | 0.030 |
Why?
|
| Information Management | 1 | 2006 | 100 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8730 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1997 | 576 | 0.030 |
Why?
|
| Hand Strength | 1 | 2018 | 462 | 0.030 |
Why?
|
| Radiography | 2 | 2013 | 6919 | 0.030 |
Why?
|
| Reading | 1 | 2008 | 539 | 0.030 |
Why?
|
| Neural Inhibition | 1 | 2009 | 589 | 0.030 |
Why?
|
| Animals | 6 | 2019 | 168764 | 0.030 |
Why?
|
| Prevalence | 2 | 2014 | 15842 | 0.030 |
Why?
|
| Fragile X Syndrome | 1 | 2016 | 116 | 0.030 |
Why?
|
| Behavior | 1 | 1997 | 535 | 0.030 |
Why?
|
| Probability | 1 | 2019 | 2475 | 0.030 |
Why?
|
| Parkinson Disease | 2 | 2020 | 2895 | 0.030 |
Why?
|
| Receptors, Opioid | 1 | 2014 | 144 | 0.030 |
Why?
|
| Ondansetron | 1 | 1994 | 95 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 2009 | 513 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 18380 | 0.030 |
Why?
|
| Magnetoencephalography | 1 | 2018 | 585 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 935 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1994 | 210 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2009 | 1735 | 0.030 |
Why?
|
| Circle of Willis | 1 | 2013 | 76 | 0.030 |
Why?
|
| Psychiatry | 1 | 1996 | 1714 | 0.030 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2013 | 101 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2013 | 128 | 0.030 |
Why?
|
| Interneurons | 1 | 2018 | 593 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2014 | 9649 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 1870 | 0.020 |
Why?
|
| Lithium | 1 | 1995 | 597 | 0.020 |
Why?
|
| Depression | 1 | 2021 | 8237 | 0.020 |
Why?
|
| Boston | 1 | 2025 | 9338 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2015 | 541 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1989 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2018 | 1140 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 2927 | 0.020 |
Why?
|
| Indians, North American | 1 | 1995 | 354 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 410 | 0.020 |
Why?
|
| Antimanic Agents | 1 | 1995 | 523 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 9747 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2015 | 542 | 0.020 |
Why?
|
| Methionine | 1 | 2013 | 569 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 26318 | 0.020 |
Why?
|
| Perception | 1 | 2007 | 1205 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4873 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2010 | 2858 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2014 | 590 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 2012 | 549 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 1370 | 0.020 |
Why?
|
| Risk Factors | 3 | 2021 | 74840 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2011 | 461 | 0.020 |
Why?
|
| Homozygote | 1 | 2013 | 1775 | 0.020 |
Why?
|
| Mesencephalon | 1 | 2000 | 338 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4958 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2878 | 0.020 |
Why?
|
| Intelligence | 1 | 2012 | 923 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 1426 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3432 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2011 | 1187 | 0.020 |
Why?
|
| Pregnancy | 2 | 2018 | 30260 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 40065 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 10603 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 8875 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 23601 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2007 | 249 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2011 | 820 | 0.010 |
Why?
|
| Comorbidity | 1 | 2010 | 10563 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8733 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14652 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7838 | 0.010 |
Why?
|
| Arousal | 1 | 2000 | 1171 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8041 | 0.010 |
Why?
|
| Respiration | 1 | 2000 | 1653 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 2007 | 705 | 0.010 |
Why?
|
| Calibration | 1 | 2005 | 814 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39193 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1823 | 0.010 |
Why?
|
| Alleles | 1 | 2013 | 6897 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5876 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18293 | 0.010 |
Why?
|
| Risk | 1 | 2013 | 9591 | 0.010 |
Why?
|
| Dopamine | 1 | 2008 | 1582 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7584 | 0.010 |
Why?
|
| Observer Variation | 1 | 2007 | 2615 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2015 | 3853 | 0.010 |
Why?
|
| Computational Biology | 1 | 2011 | 3559 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10729 | 0.010 |
Why?
|
| Neurons | 1 | 2018 | 9525 | 0.010 |
Why?
|
| Research | 1 | 1996 | 1975 | 0.010 |
Why?
|
| Asthma | 1 | 1995 | 6270 | 0.010 |
Why?
|
| United States | 2 | 2008 | 72903 | 0.010 |
Why?
|
| New Mexico | 1 | 1995 | 80 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2005 | 6255 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 81514 | 0.000 |
Why?
|